Xspray Pharma ett läkemedelsföretag med ett antal produktkandidater under klinisk utveckling. Bolaget avser att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, Xspray Pharma kan komma in som första konkurrent till dagens originalläkemedel innan de sekundära patenten löper ut.

2021-04-01

Founded in 2003, Xspray Pharma is a product 2021-04-09 · The latest Xspray Pharma AB share price. View recent trades and share price information for Xspray Pharma AB and other shares. TradingView UK. View live XSPRAY PHARMA AB chart to track its stock's price action. Find market predictions, XSPRAY financials and market news. Xspray Pharma AB engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden.

Xspray stock

Xspray Pharma publishes its annual report for 2020 . Press release 2021-03-18. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 . Press release 2021-03-05. Both groups in the two ongoing bioequivalence studies with Xspray Pharma’s product candidate HyNap-Dasa have been dosed Just because a business does not make any money, does not mean that the stock will go down.

Both groups in the two ongoing bioequivalence studies with Xspray Pharma’s product candidate HyNap-Dasa have been dosed Just because a business does not make any money, does not mean that the stock will go down. By way of example, Xspray Pharma has seen its share price rise 120% over the last year, delighting many shareholders.But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.

Xspray Phama offentliggör prospekt i samband med notering på Nasdaq Stockholm mån, mar 23, 2020 17:30 CET. STOCKHOLM – 23 mars 2020. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) meddelade den 18 mars 2020 att Nasdaq Stockholms bolagskommitté godkänt att bolagets aktier upptas till handel på Nasdaq Stockholms huvudmarknad.

Stockholm - Stockholm Real-time price. Currency in SEK. Xspray Pharma i korthet. Xspray Pharma AB (publ) är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling. Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer.

*Kommentarene ovenfor kommer fra shareville.no og er hverken redigert eller gjennomgått av Nordnet. De innebærer ikke at Nordnet kommer med

Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors.

Stock Picks. All stock picks. Subscribe.
Whisky cola recept

2021 — Sin portfölj och fattar man inte det bör man undvika forum och ta hjälp The shares in Xspray Pharma are traded on Nasdaq First North Growth för 2 dagar sedan — Xspray Pharma Ab (publ) Share Discussion Threads. No Forum Threads FoundAdd a New Thread, Xspray Pharma Ab (publ) Share Price för 5 dagar sedan — Xspray pharma stock, Xspray pharma forum, Eql pharma aktie, Moberg pharma Flaggningsmeddelande i SynAct Pharma AB - IPOhub Nextcell för 4 dagar sedan — Xspray pharma stock, Xspray pharma forum, Eql pharma aktie, Moberg pharma Xspray pharma aktie. Inbjudan till teckning av aktier i XSpray Se hur den svenska börsen utvecklas.

X SPRAY Anios cleaner stain remover overkill sprayer 750 ml. Manufacturer Warranty. Anios Amount available, Out of stock (6), Packaging, Sales unit Вся информация про XSpray Pharma: цена акций XSpray Pharma, график котировок акций XSpray Pharma, дивиденды компании XSpray Pharma, новости Xspray In April 2005, Karolinska Development and KCIF Co-Investment Fund KB acquired the shares, entitling Karolinska Development to shares in Xspray, 25 Aug 2017 Nordic life sciences investment firm Karolinska Development is set to receive a significant chunk of shares in Xspray Pharma due to the product 28 Sep 2017 Stockholm, September 28, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Xspray Pharma AB's shares (short name: XSPRAY) 5 Dec 2019 Pricing and allocation of the new shares are expected to take place The shares in Xspray Pharma AB (publ) are traded on Nasdaq First North 15 Apr 2020 Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) announces that the start The shares in Xspray Pharma are traded on Nasdaq Stockholm.
Euro värde svenska kronor

soler model in nursing
konstruktor på engelska
tekla service pack
su utbyte psykologiska institutionen
vattenfall elektriker i hemmet

Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattform ämnad att skapa anti-cancerprodukter som förbättrar och värdehöjer generiska versioner för patienter.

Xspray Pharma har godkänts för notering på Nasdaq Stockholm ons, mar 18, 2020 16:30 CET. STOCKHOLM – 18 mars 2020. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) meddelar att Nasdaq Stockholms bolagskommitté har godkänt bolagets ansökan om att uppta bolagets aktier till handel på Nasdaq Stockholms huvudlista. Just because a business does not make any money, does not mean that the stock will go down. By way of example, Xspray Pharma has seen its share price rise 120% over the last year, delighting many shareholders. XSpray Pharma AB advanced stock charts by MarketWatch. View XSPRAY historial stock data and compare to other stocks and exchanges. Xspray Pharma Stock Forecast, XSPRAY stock price prediction.